Article info

PDF

Original research article
Safety, pharmacokinetics and pharmacodynamics of AMG 811, an anti-interferon-γ monoclonal antibody, in SLE subjects without or with lupus nephritis

Authors

  1. Correspondence to Dr James B Chung; chung{at}amgen.com
View Full Text

Citation

Boedigheimer MJ, Martin DA, Amoura Z, et al
Safety, pharmacokinetics and pharmacodynamics of AMG 811, an anti-interferon-γ monoclonal antibody, in SLE subjects without or with lupus nephritis

Publication history

  • Received April 20, 2017
  • Revision received June 21, 2017
  • Accepted June 24, 2017
  • First published September 14, 2017.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.